Patents by Inventor Jean-Philippe LEYRIS

Jean-Philippe LEYRIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT3 receptor antagonists
    Patent number: 10065937
    Abstract: The invention pertains to novel FLT3 receptor antagonists of general formula (1). The compounds are useful for the treatment or the prevention of pain disorders, cancer and autoimmune diseases.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: September 4, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE STRASBOURG
    Inventors: Jean Valmier, Jean-Philippe Leyris, Didier Rognan, Martine Schmitt
  • FLT3 RECEPTOR ANTAGONISTS
    Publication number: 20170233354
    Abstract: The invention pertains to novel FLT3 receptor antagonists of general formula (1). The compounds are useful for the treatment or the prevention of pain disorders, cancer and autoimmune diseases.
    Type: Application
    Filed: July 30, 2015
    Publication date: August 17, 2017
    Inventors: Jean VALMIER, Jean-Philippe LEYRIS, Didier ROGNAN, Martine SCHMITT